Function Health: AI, Testing, and Longevity Strategy
Mark Hyman discusses the strategic shift toward preventative medicine, leveraging AI and comprehensive biomarker testing to democratize health optimization. The analysis covers the economic impact of muscle preservation, the risks of GLP-1 therapies, and the emerging market for personalized longevity interventions.